Health Volunteers
Conditions
Interventions
Protein.1
Protein.2
Protein.3
Sponsors
FANCL
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Japanese men and women aged 20 to 60 years old at the time of obtaining consent 2.Those with a BMI of 18.5 kg/m2 or more and less than 25.0 kg/m2 at screening 3.Those with a systolic blood pressure of less than 140 mmHg and a diastolic blood pressure of less than 90 mmHg at screening 4.Those who agree to participate in the study and can sign and date the consent form themselves
Exclusion criteria
Exclusion criteria: 1.Those with a serious medical history or a history of gastrointestinal resection (excluding appendectomy and endoscopic polypectomy). 2.Those with a disease that affects excretion and digestion/absorption, or those who regularly experience indigestion, constipation, diarrhea, etc. 3.Those with significantly abnormal values in blood pressure and indices of kidney function, liver function, glucose metabolism, and lipid metabolism. 4.Those who regularly use internal medicines and supplements. 5.Those who drink a lot of alcohol (more than 60g of pure alcohol per day) and those who smoke excessively (more than 20 cigarettes per day) (including those who cannot quit smoking during the time frame of their visit or cannot maintain normal mind and body by quitting smoking). 6.Those who are taking other foods, taking medicines, or applying cosmetics or quasi-drugs, or those who are participating in an intervention study or plan to participate in another study during this study. 7.Those who have donated 400mL of blood within 6 months prior to this study. 8.Those who cannot eat any food, including the test food or the standardized diet, due to food allergies or disliked ingredients. 9.Those who may be unable to ingest ingredients in the test food whose origin is not clearly stated due to religious or other reasons. 10.Those who are otherwise deemed inappropriate to participate in this study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in blood amino acids | — |
Countries
Japan
Contacts
Public ContactTsubokawa Masaya
FANCL clinical trial group
Outcome results
None listed